Abstract

ABSTRACT. Purpose: To assess the efficacy of photodynamic therapy (PDT) as a new treatment for circumscribed choroidal haemangioma (CCH). Methods: Eight patients with CCH were treated with PDT using a protocol similar to that used in the standard treatment of neovascular age‐related macular degeneration. Results: Visual acuity improved in six of eight eyes, remained unchanged in one eye and deteriorated in one eye after 3–15 months (median 7 months) follow‐up. Pre‐treatment metamorphopsia disappeared in all but two cases. The thickness of the CCH measured with standardized echography showed marked regression within 1 month after PDT. In six eyes there was no remaining protrusion after PDT and one lesion was barely detectable. One patient experienced a transient choroidal effusion and perifoveal haemorrhage. Conclusion: Photodynamic therapy is a promising new treatment for CCH as it restores visual function in most cases without causing apparent ocular or systemic side‐effects.

Keywords

MedicineMetamorphopsiaPhotodynamic therapyVisual acuityMacular degenerationOphthalmologyLesionVerteporfinSurgeryChoroidal neovascularization

Affiliated Institutions

Related Publications

Publication Info

Year
2002
Type
article
Volume
80
Issue
5
Pages
531-536
Citations
57
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

57
OpenAlex

Cite This

Irène Landau, Björn Steén, Stefan Seregard (2002). Photodynamic therapy for circumscribed choroidal haemangioma. Acta Ophthalmologica Scandinavica , 80 (5) , 531-536. https://doi.org/10.1034/j.1600-0420.2002.800513.x

Identifiers

DOI
10.1034/j.1600-0420.2002.800513.x